1. Home
  2. RMAX vs ASMB Comparison

RMAX vs ASMB Comparison

Compare RMAX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMAX
  • ASMB
  • Stock Information
  • Founded
  • RMAX 1973
  • ASMB 2005
  • Country
  • RMAX United States
  • ASMB United States
  • Employees
  • RMAX N/A
  • ASMB N/A
  • Industry
  • RMAX Real Estate
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMAX Finance
  • ASMB Health Care
  • Exchange
  • RMAX Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • RMAX 168.1M
  • ASMB 141.8M
  • IPO Year
  • RMAX 2013
  • ASMB 2010
  • Fundamental
  • Price
  • RMAX $8.04
  • ASMB $23.97
  • Analyst Decision
  • RMAX Hold
  • ASMB Strong Buy
  • Analyst Count
  • RMAX 2
  • ASMB 3
  • Target Price
  • RMAX $9.75
  • ASMB $33.00
  • AVG Volume (30 Days)
  • RMAX 258.2K
  • ASMB 53.4K
  • Earning Date
  • RMAX 07-29-2025
  • ASMB 08-06-2025
  • Dividend Yield
  • RMAX N/A
  • ASMB N/A
  • EPS Growth
  • RMAX N/A
  • ASMB N/A
  • EPS
  • RMAX 0.48
  • ASMB N/A
  • Revenue
  • RMAX $298,162,000.00
  • ASMB $33,247,000.00
  • Revenue This Year
  • RMAX N/A
  • ASMB $0.04
  • Revenue Next Year
  • RMAX $1.64
  • ASMB N/A
  • P/E Ratio
  • RMAX $16.67
  • ASMB N/A
  • Revenue Growth
  • RMAX N/A
  • ASMB 54.77
  • 52 Week Low
  • RMAX $6.90
  • ASMB $7.75
  • 52 Week High
  • RMAX $14.31
  • ASMB $23.97
  • Technical
  • Relative Strength Index (RSI)
  • RMAX 49.53
  • ASMB 77.03
  • Support Level
  • RMAX $7.45
  • ASMB $16.90
  • Resistance Level
  • RMAX $8.16
  • ASMB $19.43
  • Average True Range (ATR)
  • RMAX 0.35
  • ASMB 1.41
  • MACD
  • RMAX -0.03
  • ASMB 0.36
  • Stochastic Oscillator
  • RMAX 49.69
  • ASMB 100.00

About RMAX RE/MAX Holdings Inc.

RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: